article thumbnail

The Committee to Restore Nymox Shareholder Value Sends Letter to Nymox Pharmaceutical Shareholders and Issues Proxy Materials for Upcoming Special Meeting

Digital Health Global

CRNSV”) was formed by former executives and directors of Nymox Pharmaceutical Corporation (“Nymox” or the “Company”), who were improperly removed from their positions, with a goal to recover shareholder value in Nymox. From 2008 until 2010, Mr. Cutler was President and Chief Executive Officer of Sustainable Power Corp.,

article thumbnail

McKinsey’s Six Shifts To Add Life to Years — and One More to Consider

Health Populi

To innovate more, and more quickly, across the entire ecosystem of health — in government policies, pharmaceutical innovations, and technology developments. To scale what works, based on evidence and proven interventions — which depends on our reducing biases in our assumptions, models and strategies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Americans’ Trust in the Healthcare System Low Compared to Rest-of-World’s Health Citizens

Health Populi

Health Populi’s Hot Points: Trust is a precursor for health engagement, Edelman’s Health Engagement taught us in 2010, and that lesson is crucial to dot-connect with the 2018 data for U.S. health ecosystem stakeholders. That’s because the U.S.

BioTech 185
article thumbnail

Medicine 2.0 : Implications of Connected Medical Devices & Digital Healthcare

Lloyd Price

In October 2010, the US Federal Communications Commission and the US Food and Drug Administration (FDA) partnered to encourage investment in wireless healthcare devices, and the European authorities have become increasingly willing to give such solutions the CE marking required on drug products to be sold in Europe. Source : [link]

article thumbnail

Spending on Medicines In and Post-COVID Say a Lot About Patients and Larger Healthcare Trends – an IQVIA Update

Health Populi

In the ten developed countries in the IQVIA Institute forecast, oncology has the greatest burden of disease, spending for which increased at a rate of 14% annually looking back to 2010 to 2019. Going forward 2021 to 2025, shown here, we can expect oncology to grow by between 9% and 12% globally.